Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02680743 · ClinicalTrials.gov registry record · NA
Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02680743 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 60 participants.
The verdict
NCT02680743, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Congenital cytomegalovirus (cCMV) is the most common non-genetic cause of pediatric hearing loss and an important cause of neurodevelopmental delay. Symptomatic infants are readily identified and quickly referred for treatment, but the majority of infants (85-90%) with cCMV show no symptoms at birth and therefore do not receive timely treatment. Often, these otherwise asymptomatic infants with cCMV may have early congenital hearing loss and therefore fail the newborn hearing screen, but because they are not specifically identified as having cCMV there is a delay in seeking further audiology exam and treatment of the CMV infection. This study will investigate how testing newborns for congenital cytomegalovirus infection (cCMV) after a failed newborn hearing screens can improve early identification of cCMV infection and therefore reduce the delay in referral of the newborn to appropriate specialists for intervention.
Interventions
- OTHER Education of parents to pursue prompt hearing screening.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-03-28 |
| Est. Completion | 2018-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02680743
The ClinicalTrials.gov registry entry for NCT02680743 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Education of parents to pursue prompt hearing screening. is the first listed.
NCT02680743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02680743 about?
NCT02680743 is a clinical study titled "Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit". Congenital cytomegalovirus (cCMV) is the most common non-genetic cause of pediatric hearing loss and an important cause of neurodevelopmental delay. Symptomatic infants are readily identified and quickly referred for treatment, but the majority of infants (85-90%) with cCMV show no symptoms at birth...
What is the current status of trial NCT02680743?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-03-28. Estimated completion is 2018-05-01.
What interventions are being tested in trial NCT02680743?
The interventions under investigation include: Education of parents to pursue prompt hearing screening. (OTHER).
Who is sponsoring clinical trial NCT02680743?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.